Another promising anticancer peptide is NuBCP9 (FSRSLHSLL), which is able to bind the Bcl-2 protein, highly overexpressed in cancer cells, turning a cell protector into an apoptosis inductor [138]. This evidence concerns the gene BCL2 and cancer.